Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment

  • Doreen Huebner1,
  • Christiane Rieger1,
  • Ralf Bergmann2,
  • Martin Ullrich2,
  • Sebastian Meister2,
  • Marieta Toma3,
  • Ralf Wiedemuth4,
  • Achim Temme4, 5, 6,
  • Vladimir Novotny1,
  • Manfred P. Wirth1, 5, 6,
  • Michael Bachmann2, 5, 6, 7,
  • Jens Pietzsch2, 8 and
  • Susanne Fuessel1, 6Email author
BMC Cancer201717:790

https://doi.org/10.1186/s12885-017-3778-3

Received: 9 July 2017

Accepted: 13 November 2017

Published: 23 November 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
9 Jul 2017 Submitted Original manuscript
2 Aug 2017 Reviewed Reviewer Report - Teruo Inamoto
5 Sep 2017 Reviewed Reviewer Report - Eddie Chan
12 Sep 2017 Author responded Author comments - Doreen Huebner
Resubmission - Version 2
12 Sep 2017 Submitted Manuscript version 2
25 Oct 2017 Author responded Author comments - Doreen Huebner
Resubmission - Version 3
25 Oct 2017 Submitted Manuscript version 3
Publishing
13 Nov 2017 Editorially accepted
23 Nov 2017 Article published 10.1186/s12885-017-3778-3

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Urology, University Hospital Carl Gustav Carus, Technische Universität Dresden
(2)
Department Radiopharmaceutical and Chemical Biology, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Institute of Radiopharmaceutical Cancer Research
(3)
Institute of Pathology, University Hospital Carl Gustav Carus, Technische Universität Dresden
(4)
Department of Neurosurgery, Section Experimental Neurosurgery & Tumor Immunology, University Hospital Carl Gustav Carus, Technische Universität Dresden
(5)
German Cancer Consortium (DKTK), partner site Dresden, Germany, and German Cancer Research Center (DKFZ)
(6)
National Center for Tumor Diseases (NCT) Dresden, University Hospital Carl Gustav Carus, Technische Universität Dresden
(7)
UniversityCancerCenter (UCC), University Hospital Carl Gustav Carus, Technische Universität Dresden
(8)
Department of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden

Advertisement